ロード中...
Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model
Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, and...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2018-11-01
|
| シリーズ: | Brazilian Journal of Infectious Diseases |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S1413867018304975 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|